000 01214 a2200337 4500
005 20250518060115.0
264 0 _c20191203
008 201912s 0 0 eng d
022 _a1873-4294
024 7 _a10.2174/1568026619666190904163524
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHoo, Winfrey Pui Yee
245 0 0 _aOverview of Current Immunotherapies Targeting Mutated KRAS Cancers.
_h[electronic resource]
260 _bCurrent topics in medicinal chemistry
_c2019
300 _a2158-2175 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents, Immunological
_xpharmacology
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aMutation
650 0 4 _aNeoplasms
_xgenetics
650 0 4 _aOncogene Protein p21(ras)
_xantagonists & inhibitors
650 0 4 _aProto-Oncogene Mas
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aVaccines
_ximmunology
700 1 _aSiak, Pui Yan
700 1 _aIn, Lionel L A
773 0 _tCurrent topics in medicinal chemistry
_gvol. 19
_gno. 23
_gp. 2158-2175
856 4 0 _uhttps://doi.org/10.2174/1568026619666190904163524
_zAvailable from publisher's website
999 _c30074836
_d30074836